Interpreting the RAPIDO trial: factors to consider

Jonathan B. Yuval; Sujata Patil; Julio Garcia-Aguilar

doi:10.1016/S1470-2045(21)00061-9

Interpreting the RAPIDO trial: factors to consider

Jonathan B. Yuval, Sujata Patil, Julio Garcia-Aguilar

Memorial Sloan-Kettering Cancer Center

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e87-e88
Journal	The Lancet Oncology
Volume	22
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(21)00061-9
State	Published - Mar 2021
Externally published	Yes

Funding

Funders	Funder number
National Cancer Institute	T32CA009501

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(21)00061-9

Cite this

@article{ea6f0b3156dc424a852e65136e1f89e9,

title = "Interpreting the RAPIDO trial: factors to consider",

author = "Yuval, {Jonathan B.} and Sujata Patil and Julio Garcia-Aguilar",

year = "2021",

month = mar,

doi = "10.1016/S1470-2045(21)00061-9",

language = "אנגלית",

volume = "22",

pages = "e87--e88",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - Interpreting the RAPIDO trial

T2 - factors to consider

AU - Yuval, Jonathan B.

AU - Patil, Sujata

AU - Garcia-Aguilar, Julio

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85101723906&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(21)00061-9

DO - 10.1016/S1470-2045(21)00061-9

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 33662295

AN - SCOPUS:85101723906

SN - 1470-2045

VL - 22

SP - e87-e88

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -

Interpreting the RAPIDO trial: factors to consider

Funding

UN SDGs

Access to Document

Other files and links

Cite this